Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pfizer
Biotech
Pfizer inks $4.9B Metsera buyout to beef up obesity pipeline
Having seen its internal assets flounder, the Big Pharma has struck a deal to buy Metsera for to secure a pipeline of injectable and oral candidates.
Nick Paul Taylor
Sep 22, 2025 7:47am
Fierce Pharma
ACIP narrowly votes against COVID vaccine prescriptions
Sep 19, 2025 5:22pm
Pfizer, Arvinas lose interest in commercializing PROTAC drug
Sep 18, 2025 7:35am
Sanofi becomes latest pharma to hold fire on UK R&D investments
Sep 15, 2025 10:14am
Pfizer, Valneva boosted by updated Lyme vaccine data
Sep 3, 2025 10:19am
Pfizer's SCD drug fails ph. 3 study in latest blow to GBT legacy
Aug 18, 2025 7:31am